Search

Advertise with Us

Email this article to your friend

 

 

Does a Tablet Work as Well as Shots for Allergy Sufferers?

 

Volunteers Needed for Saint Louis University Research

May 5, 2008 -- ST. LOUIS - Allergy sufferers who want permanent relief typically have to undergo a series of shots, sometimes over the course of several years, to desensitize them to whatever allergen causes their stuffy nose, sneezing and itchy, watery eyes.

 

Soon, however, researchers at Saint Louis University will begin studying whether a single small tablet placed under the tongue daily for several months can do the job just as well as shots can.
 
“We want to find out whether there’s an alternative to allergy shots for patients who have allergic respiratory disorders,” said Raymond G. Slavin, M.D., professor of internal medicine at Saint Louis University, a SLUCare allergist and the study’s principal investigator locally.  “Certainly, a tablet is safer and much more convenient than a shot – and for most people, it’s much more pleasant.”

 

For their study, Slavin and his colleagues will examine the effect of an oral medication on people who are allergic to grass pollen – one of the most common outdoor allergens and one that typically causes often-severe hay fever symptoms in people sensitive to it.  In the St. Louis area, grass pollen season generally stretches from May through mid-July.
 
“If our study finds that this tablet is effective as an alternative to shots, there’s no reason to believe that oral medications couldn’t be developed for a whole range of other allergens,” Slavin said. “This could be quite promising.”
 
The study, which is being conducted at multiple sites around the country, will last about 19 months. 
 
During the first year, patients enrolled in the study will be observed periodically to determine the severity of their allergy to grass pollen.  The oral medication being studied will not be administered during this phase, though patients will provided medications to help relieve and control allergy symptoms.
 
Those whose grass pollen allergy is deemed significant enough will move onto the study’s treatment phase next year.  Patients will be randomly designated to receive either the study medication or a placebo, which they’ll take daily for 12 to 16 weeks before and during grass pollen season. 
 
Patients will be observed periodically throughout the treatment phase to see how they’re responding to the medication (or placebo).  The medical professionals assessing the response will not know which treatment – the medication or placebo – the patient received.
 
For the study, SLU researchers hope to enroll up to 20 volunteers who are 18 to 50 years old and of either gender and any race. They must have been previously diagnosed with significant allergies by a physician and, last year, received treatment during grass pollen season.  Among other criteria, they may not have received regular medication for allergens other than grass pollen.
 
Volunteers will be given all study-related medication and medical care at no cost, and they will be reimbursed for time and travel.
 
People wanting more information or to find out whether they’re eligible to participate in the study should call 314-977-4440, or 866-977-4440.
 
Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national and international level. Research at the school seeks new cures and treatments in five key areas: cancer, liver disease, heart/lung disease, aging and brain disease, and infectious disease.

 
Source: http://www.slu.edu/

Email this article to your friend

Copyright © 2003-2008 HealthOrbit, Inc. All rights reserved.